Objectives:
Explain how this individualized immunotherapy helps treat relapsed/refractory B-cell malignancies
Describe how leukapheresis factors can affect the quality and T-cell content of the manufacturer product
List challenges in obtaining optimal leukapheresis products and how these can be addressed

 

Presented by:

Drs. Valentina Baez Sosa, David Daniel, Linda Song (NIH TM fellows)

Session date: 
08/16/2023 - 3:30pm to 4:30pm EDT
Location: 
Zoom
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Completion
  • 1.00 Nursing CEU

Please login or register to take this course.